Boss 'delighted' as Abingdon Health reveals 31 per cent revenue growth

York-based Abingdon Health says its revenues have grown by more than 30 per cent – with further increases expected.

The company, which develops and manufactures rapid diagnostic tests and med-tech, has issued a trading update for the financial year to the end of June 2026.

It said it had achieved strong growth in the second half of the financial year, with total revenue for the full year expected to reach £11.3m – 31 per cent on the £8.6m recorded 12 months before. It said there was a 63 per cent increase in revenue during the second half of the year compared to the first six months of it.

Dr Chris Hand, Executive Chairman of Abingdon Health, said: “We are delighted to announce revenue growth of over 30 per cent and a move into adjusted EBITDA profitability in the second half of the year.

Dr Chris Hand, executive chairman of Abingdon Healthplaceholder image
Dr Chris Hand, executive chairman of Abingdon Health

"The CDMO [contract development and manufacturing organisation] contracts announced during the previous financial year provide a strong foundation for significant revenue growth in FY27.

"Abingdon Health is well-positioned to build on this momentum through our integrated, end-to-end service offering and our growing international footprint, particularly servicing clients in the US.”​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

The group’s results for the year will be published in early October.​​​​​​​

Related topics:
News you can trust since 1754
Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice